First-In-Human (FIH), Single Ascending Dose (SAD) Study and Multiple Ascending Dose (MAD) Study of SP-101 Injection

Clinical trial NCT07334249 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07334249
Sponsor: Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Major Depressive Disorder, Healthy Volunteer

Start date: 2025-12-23
Primary completion: 2026-06-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.